History of Vaccination

The practice has no securely demonstrated single birthplace. The earliest firm written discussions are from the mid-sixteenth century: Chinese sources describe placing prepared smallpox material in the nose, while eighteenth-century observers reported skin inoculation in Bengal and elsewhere. Claims that variolation was practised in China around 1000 or described in ancient Sanskrit medicine rest on much later traditions, not contemporary documentation. By the seventeenth century, related skin inoculation practices were established in parts of North and West Africa and among Christian communities in the Ottoman Empire. [1]

Knowledge travelled by more than one route. In Constantinople in 1717, Lady Mary Wortley Montagu described women performing inoculation and later arranged the procedure for her son and, after returning to England, her daughter. Her advocacy mattered in Britain, but it did not create the Ottoman practice she observed. Reports by the physicians Emanuel Timonius and Jacobus Pylarinus had already reached the Royal Society. [1]

In Boston, the enslaved African man Onesimus told the minister Cotton Mather that an operation in Africa had protected him from smallpox and showed the scar it left. During the 1721 epidemic, Mather urged local physicians to inoculate; Zabdiel Boylston did so and published in defence of the practice. Their surviving accounts were written by clergymen and physicians, not by Onesimus, and therefore preserve African knowledge through the words and interests of slaveholders. Boylston's pamphlet also abridged Timonius's and Pylarinus's reports and answered religious objections, showing how medical experiment, print, and theology were entangled. [2]

On 14 May 1796, the Gloucestershire surgeon Edward Jenner inserted material from a cowpox lesion on the hand of dairy worker Sarah Nelmes into cuts on the arm of eight-year-old James Phipps, his gardener's son. Jenner later challenged Phipps with variolous material, and Phipps did not develop smallpox. Jenner reported this case and a larger series in An Inquiry into the Causes and Effects of the Variolae Vaccinae (1798). [3] [4]

The Inquiry is both evidence and advocacy: Jenner selected cases to persuade readers that cowpox could protect against smallpox, at a time before controlled trials, microbiology, or research-ethics review. Its account does not document consent in the modern sense, and deliberately exposing a child to smallpox material would not meet present standards. Nor was Jenner necessarily the first person to test the protective effects of cowpox. Later accounts credit farmer Benjamin Jesty with inoculating his family in 1774 and mention other observations, but their documentation and contemporary circulation are much weaker. Jenner's defensible historical significance lies in sustained investigation, publication, and promotion, not an unqualified claim to sole invention. [5]

Translations helped the method travel: the National Library of Medicine records Portuguese, French, Dutch, Italian, and Japanese editions within two decades of Jenner's publication. Yet the substance used later was not simply a stable sample of the cowpox in Jenner's first case. Nineteenth- century vaccinators maintained material through repeated passage, and the origin of the virus later called vaccinia remains uncertain. [4] [5]

The Spanish Crown's Royal Philanthropic Vaccine Expedition left A Coruña in November 1803 under Francisco Xavier de Balmis. Twenty-two children from a foundling institution carried vaccine across the Atlantic through sequential arm-to-arm inoculation; other children sustained it on later routes. José Salvany led a branch through South America, while Balmis's route continued through Mexico and the Philippines. The expedition also aimed to establish vaccination boards and train practitioners so that a supply would remain after it moved on. [6]

Calling this only a philanthropic triumph conceals its ethical structure. Some carrier children were wards of institutions and could not give meaningful consent; their labour and later lives are far less fully documented than Balmis's leadership. At the same time, the expedition was not the sole source of vaccination everywhere it arrived: local initiatives sometimes preceded it, and durable programmes depended on nurses, caretakers, clergy, administrators, parents, and practitioners whose names were seldom preserved. [6]

British India likewise resists a simple story of a European technology imposed on passive recipients. Cowpox vaccination competed with existing variolation; supplies failed in heat and transit; and policies varied by presidency, province, budget, and official. Indian vaccinators, local authorities, and families negotiated, adapted, or refused the procedure. Historians Sanjoy Bhattacharya, Mark Harrison, and Michael Worboys therefore describe a “fractured” colonial state rather than a single coherent machine. [7]

In England and Wales, the 1853 Vaccination Act required infant smallpox vaccination, with later legislation strengthening enforcement. Local officials prosecuted parents, and penalties fell heavily on working-class families. Organized anti-vaccination societies used lectures, petitions, newspapers, court cases, and mass demonstrations. Some claims about vaccine injury were unsupported, but the movement's political questions—who bore risk, who certified safety, and how far government power should reach—were substantive features of Victorian public health. [9]

Parliament's 1898 debate records a compromise: parents who satisfied a court that they conscientiously believed vaccination would harm their child could avoid penalties. This is a primary source for legislators' arguments, not a neutral measure of vaccine safety or popular opinion. The new phrase “conscientious objection” acquired a specific statutory place through conflict over vaccination, while practical access to exemption still depended on magistrates. [10]

Elsewhere, mandates worked through different institutions: military recruitment, schools, municipal ordinances, and colonial emergency powers. Acceptance could rise when disease was visible and fall when it receded; refusal could also reflect inaccessible clinics, failed vaccine, coercive encounters, or distrust earned by other state actions. “Hesitancy” is therefore a useful modern label only if it does not erase the distinct politics and material conditions of each place and period.

A 1901 disaster in St Louis killed thirteen children who received diphtheria antitoxin contaminated with tetanus. Antitoxin is a treatment made from protective antibodies, not a vaccine, but the episode exposed the lack of uniform control over biological products. The United States' Biologics Control Act of 1902 introduced federal licensing, inspections, and labelling requirements for vaccines, sera, and antitoxins. [11]

The 1954 US field trial of Jonas Salk's inactivated polio vaccine involved about 1.8 million children and depended on schools, local health departments, medical workers, hundreds of thousands of lay volunteers, and the National Foundation for Infantile Paralysis. Some areas used randomized placebo controls and others observed controls, so “the trial” was a large civic and administrative undertaking as well as a statistical experiment. [12]

Licensing in April 1955 was followed by the Cutter incident: two batches made by Cutter Laboratories contained live poliovirus, and more than 260 people contracted polio in vaccine-associated chains of infection. US authorities suspended vaccination while manufacturers and procedures were reinspected. The effective Salk vaccine and the production failure must be kept analytically separate, but the incident showed that a sound principle could still harm patients when validation and manufacturing controls failed. [11]

The World Health Assembly endorsed global smallpox eradication in 1959, but the early effort lacked staff and money and relied heavily on reaching mass-coverage targets. An intensified programme began in 1967. At that point vaccine quality varied markedly among producers; WHO reference laboratories, training, seed lots, and potency and heat-stability tests helped make freeze-dried vaccine dependable in tropical field conditions. The bifurcated needle reduced the skill and vaccine volume needed for each successful vaccination. [5]

Teams increasingly combined vaccination with active surveillance and containment: searching for cases, confirming diagnoses, isolating patients, tracing contacts, and vaccinating around outbreaks. In India, local and international workers conducted house-to-house searches and used rewards for reports; elsewhere programmes adapted transport, publicity, and case finding to local conditions. Mass vaccination remained important, but a dose administered far from a chain of transmission was not equivalent to a case found and contained. [13] [5]

The last naturally acquired case was recorded in Somalia on 26 October 1977. A laboratory-associated outbreak occurred in Birmingham in 1978, underscoring that interrupted natural transmission did not remove every risk. After certification work in countries around the world, the World Health Assembly endorsed eradication on 8 May 1980. The result belonged not to one inventor or agency but to national programmes and hundreds of thousands of vaccinators, surveillance officers, laboratory workers, drivers, interpreters, community leaders, and residents. [5] [13]

Most vaccine-preventable infections cannot be eradicated by repeating the smallpox formula. They may have animal reservoirs, spread before cases are recognized, require several doses, or persist where health systems cannot reliably reach people. Salk's injected polio vaccine and the live oral vaccines developed by Albert Sabin and others, for example, became tools in different national and international strategies; neither made delivery, surveillance, or inequality disappear. [8]

In 1974, WHO established the Expanded Programme on Immunization to help countries build routine programmes against diphtheria, measles, pertussis, polio, tetanus, and tuberculosis. That shift joined vaccine history to the everyday work of maternal and child health: procurement, refrigeration, transport, registers, repeat appointments, training, and communication. Coverage figures consequently describe the reach of health systems as well as the availability of biomedical products. [14]

The long history corrects three durable myths. Jenner did not invent the idea of induced protection from nothing; laboratory vaccines were not all variants of his cowpox procedure; and smallpox did not disappear through a vaccine alone. Vaccination succeeded when knowledge, biological material, regulation, labour, and public cooperation held together—and failed or caused harm when one of those systems broke down.